{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:58:23Z","timestamp":1779926303719,"version":"3.53.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139694","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T18:04:20Z","timestamp":1444154660000},"page":"e0139694","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Jackalina M.","family":"Van Kampen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Baranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis G.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ana.21832","article-title":"Modeling Parkinson&apos;s disease","volume":"66","author":"CW Olanow","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson&apos;s disease","volume":"16","author":"N Schintu","year":"2009","journal-title":"Neurotoxicol Res"},{"issue":"40","key":"ref3","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser\u2013129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"JP Anderson","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25108","article-title":"Animal models of Parkinson&apos;s disease: limits and relevance to neuroprotection studies","volume":"28","author":"E Bezard","year":"2013","journal-title":"Mov Disord"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson&apos;s disease","volume":"3","author":"R Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/NMM:1:3:207","article-title":"Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour","volume":"1","author":"JM Wilson","year":"2002","journal-title":"Neuromolecular Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.mehy.2004.12.033","article-title":"Cycad toxins, <italic>Helicobacter pylori<\/italic> and parkinsonism: Cholesterol glucosides as the common denomenator","volume":"66","author":"JD Schulz","year":"2006","journal-title":"Med Hypotheses"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12017-007-8020-z","article-title":"Chronic exposure to dietary sterol glucosides is neurotoxic to motor neurons and induces an ALS-PDC phenotype","volume":"10","author":"R Tabata","year":"2008","journal-title":"Neuromolecular Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1471-4159.2002.00976.x","article-title":"Isolation of various forms fo sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex","volume":"82","author":"I Khabazian","year":"2002","journal-title":"J Neurochem"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ana.22018","article-title":"Environmental neurotoxin-induced progressive model of parkinsonism in rats","volume":"68","author":"WB Shen","year":"2010","journal-title":"Ann Neurol"},{"issue":"Suppl. 1","key":"ref11","first-page":"3","article-title":"Abstracts of the Third World Parkinson Congress, October 1\u20134, 2013, Montreal, Canada","volume":"3","author":"JM Van Kampen","year":"2013","journal-title":"Journal of Parkinson's Disease"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exger.2013.11.012","article-title":"Panax ginseng is neuroprotective in a novel progressive model of Parkinson&apos;s disease","volume":"50","author":"JM Van Kampen","year":"2014","journal-title":"Exp Gerontol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.24954","article-title":"Premotor Parkinson&apos;s disease: concepts and definitions","volume":"27","author":"A Siderowf","year":"2012","journal-title":"Mov Disord"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.24892","article-title":"Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study","volume":"27","author":"A Siderowf","year":"2012","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","article-title":"Dementia and survival in Parkinson disease: a 12-year population study","volume":"70","author":"TC Buter","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","article-title":"The neurobiological basis of spontaneous alternation","volume":"26","author":"R Lalonde","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"I Daisuke","year":"1998","journal-title":"Mol Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11064-011-0662-4","article-title":"Pathobiochemical effect of acylated steryl-\u03b2-glucoside on aggregation and cytotoxicity of \u03b1-synuclein","volume":"37","author":"S Usuki","year":"2012","journal-title":"Neurochem Res"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.cdd.4401778","article-title":"ER stress and neurodegenerative diseases","volume":"13","author":"D Lindholm","year":"2006","journal-title":"Cell Death and Differentiation"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-4159.2010.07143.x","article-title":"Induction of the unfolded protein response by \u03b1-synuclein in experimental models of Parkinson&apos;s disease","volume":"116","author":"A Belluci","year":"2011","journal-title":"J Neurochem"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2012.12.005","article-title":"An ERcentric view of Parkinson&apos;s disease","volume":"19","author":"G Mercado","year":"2013","journal-title":"Trends Mol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/gerona\/61.5.435","article-title":"The effect of aging on the chaperone concentrations in the hepatic, endoplasmic reticulum of male rats: the possible role of protein misfolding due to the loss of chaperones in the decline in physiological function seen with age","volume":"61","author":"RR Erickson","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"RL Doty","year":"2012","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does Parkinson disease pathology begin in the brain?","volume":"61","author":"K Del Tredici","year":"2002","journal-title":"J Neuropath Exp Neurol"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00415-011-5915-2","article-title":"Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson&apos;s disease","volume":"258","author":"TM Rolheiser","year":"2011","journal-title":"Journal of Neurology"},{"key":"ref27","article-title":"Olfactory dysfunction in incidental Lewy body disease and Parkinson&apos;s disease","author":"E Driver-Dunckley","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/WCO.0000000000000113","article-title":"Treatment of early Parkinson&apos;s disease","volume":"27","author":"R Pahwa","year":"2014","journal-title":"Current Opinion in Neurology"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"e77509","DOI":"10.1371\/journal.pone.0077509","article-title":"Olfaction in three genetic and two MPTP-induced Parkinson&apos;s disease mouse models","volume":"8","author":"S Kurtenbach","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00429-011-0347-4","article-title":"\u03b1-Synuclein in the olfactory system of a mouse model of Parkinson&apos;s disease: correlation with olfactory projections","volume":"217","author":"I Ubeda-Ba\u00f1on","year":"2012","journal-title":"Brain Structure & Function"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","article-title":"Olfactory deficits in mice overexpressing human wildtype alpha-synuclein","volume":"28","author":"SM Fleming","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson&apos;s disease-related pathology","volume":"318","author":"H Braak","year":"2004","journal-title":"Cell Tissue Research"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1212\/01.WNL.0000163993.82388.C8","article-title":"Parkinson disease: Handedness predicts asymmetry","volume":"64","author":"RJ Uitti","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13803395.2012.751966","article-title":"The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na\u00efve patients with Parkinson&apos;s disease","volume":"35","author":"M Poletti","year":"2013","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1474-4422(06)70549-X","article-title":"The mystery of motor asymmetry in Parkinson&apos;s disease","volume":"5","author":"R Djaldetti","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp.52.1.72","article-title":"Asymmetry of substantia nigra neuronal loss in Parkinson&apos;s disease and its relevance to the mechanism of levodopa-related motor fluctuations","volume":"52","author":"PA Kempster","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"MM Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"CG Goetz","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 17","key":"ref39","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1002\/mds.21683","article-title":"Cholinergic and other neurotransmitter mechanisms in Parkinson&apos;s disease, Parkinson&apos;s disease dementia, and dementia with Lewy bodies","volume":"22","author":"PT Francis","year":"2007","journal-title":"Mov Disord"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson&apos;s disease","volume":"20","author":"D Aarsland","year":"2005","journal-title":"Movement Disorders"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0967-5868(96)90028-4","article-title":"A longitudinal study of Parkinson&apos;s disease: Clinical and neuropsychological correlates of dementia","volume":"3","author":"WG Reid","year":"1996","journal-title":"Journal of Clinical Neuroscience"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1212\/WNL.39.4.610-a","article-title":"Parkinson&apos;s disease and dementia","volume":"39","author":"AC Taylor","year":"1989","journal-title":"Neurology"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00702-013-1084-z","article-title":"A quantitative study of \u03b1-synuclein pathology in fifteen cases of dementia associated with Parkinson disease","volume":"121","author":"RA Armstrong","year":"2014","journal-title":"J Neural Transm"},{"issue":"Pt 9","key":"ref44","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson&apos;s disease","volume":"137","author":"H Hall","year":"2014","journal-title":"Brain"},{"issue":"23","key":"ref45","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson&apos;s disease and Lewy body dementia hippocampus contains \u03b1-, \u03b2-, and \u03b3-synuclein","volume":"96","author":"JE Galvin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson&apos;s disease","volume":"24","author":"H Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson&apos;s disease dementia","volume":"72","author":"DJ Irwin","year":"2012","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"ref48","first-page":"82","article-title":"Evidence in favor of Braak staging of Parkinson&apos;s disease","volume":"25","author":"D Dickson","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-3565(25)24468-8","article-title":"On the mechanisms underlying 1-methyl-4-phenyl = 1,2,3,6-tetraydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin&apos;s metabolic patterns in brain microvessels and liver","volume":"244","author":"NJ Riachi","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1742-4658.2008.06302.x","article-title":"Parkinson&apos;s disease: genetic versus toxin-induced rodent models","volume":"275","author":"M Terzioglu","year":"2008","journal-title":"FEBS Journal"},{"issue":"6","key":"ref51","first-page":"435","article-title":"Liver X receptors, nervous system, and lipid metabolism","volume":"36","author":"G Cermenati","year":"2013","journal-title":"Journal of Endocrinological Investigation"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1471-4159.2008.05736.x","article-title":"Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells","volume":"107","author":"JP Rantham Prabhakara","year":"2008","journal-title":"J Neurochem"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1471-4159.2011.07497.x","article-title":"The oxysterol 27-hydroxycholesterol regulates \u03b1-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors\u2014relevance to Parkinson&apos;s disease","volume":"119","author":"G Marwarha","year":"2011","journal-title":"J Neurochem"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","article-title":"Acceleration of \u03b1-synuclein aggregation by exosomes","volume":"290","author":"M Grey","year":"2015","journal-title":"J Biol Chem"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbalip.2006.03.015","article-title":"Dietary plant sterols accumulate in the brain","volume":"1761","author":"PJ Jansen","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1073\/pnas.0711599105","article-title":"Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson&apos;s dementia","volume":"105","author":"HJ Kim","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.06.026","article-title":"New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism","volume":"203","author":"L Calpe-Berdiel","year":"2009","journal-title":"Atherosclerosis"},{"issue":"32","key":"ref58","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1073\/pnas.1210833109","article-title":"Liver X receptor \u03b2 protects dopaminergic neurons in a mouse model of Parkinson&apos;s disease","volume":"109","author":"YB Dai","year":"2012","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:50:32Z","timestamp":1748645432000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139694"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139694","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}